These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 29845614)

  • 1. Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis.
    Yang T; Li Z; Jiang L; Wang Y; Xi X
    Acta Neurol Scand; 2018 Aug; 138(2):104-114. PubMed ID: 29845614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticosteroid use and intensive care unit-acquired weakness: a systematic review and meta-analysis.
    Yang T; Li Z; Jiang L; Xi X
    Crit Care; 2018 Aug; 22(1):187. PubMed ID: 30075789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperlactacidemia as a risk factor for intensive care unit-acquired weakness in critically ill adult patients.
    Yang T; Li Z; Jiang L; Xi X
    Muscle Nerve; 2021 Jul; 64(1):77-82. PubMed ID: 33831220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early rehabilitation reduces the likelihood of developing intensive care unit-acquired weakness: a systematic review and meta-analysis.
    Anekwe DE; Biswas S; Bussières A; Spahija J
    Physiotherapy; 2020 Jun; 107():1-10. PubMed ID: 32135387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical review: intensive care unit acquired weakness.
    Hermans G; Van den Berghe G
    Crit Care; 2015 Aug; 19(1):274. PubMed ID: 26242743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive Care Unit- Acquired Weakness and Hospital Functional Mobility Outcomes Following Invasive Mechanical Ventilation in Patients with COVID-19: A Single-Centre Prospective Cohort Study.
    Núñez-Seisdedos MN; Lázaro-Navas I; López-González L; López-Aguilera L
    J Intensive Care Med; 2022 Aug; 37(8):1005-1014. PubMed ID: 35578542
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnostic tools of intensive care unit acquired weakness: a systematic review].
    Wu Y; Ding N; Jiang B; Zhang Z; Zhang C; Li B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Dec; 30(12):1154-1160. PubMed ID: 30592950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of risk factors for intensive care unit acquired weakness.
    Yang Z; Wang X; Wang F; Peng Z; Fan Y
    Medicine (Baltimore); 2022 Oct; 101(43):e31405. PubMed ID: 36316900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis.
    Price DR; Mikkelsen ME; Umscheid CA; Armstrong EJ
    Crit Care Med; 2016 Nov; 44(11):2070-2078. PubMed ID: 27513545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive care unit-acquired weakness.
    Horn J; Hermans G
    Handb Clin Neurol; 2017; 141():531-543. PubMed ID: 28190434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propofol as a Risk Factor for ICU-Acquired Weakness in Septic Patients with Acute Respiratory Failure.
    Abdelmalik PA; Rakocevic G
    Can J Neurol Sci; 2017 May; 44(3):295-303. PubMed ID: 28091345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An official American Thoracic Society Clinical Practice guideline: the diagnosis of intensive care unit-acquired weakness in adults.
    Fan E; Cheek F; Chlan L; Gosselink R; Hart N; Herridge MS; Hopkins RO; Hough CL; Kress JP; Latronico N; Moss M; Needham DM; Rich MM; Stevens RD; Wilson KC; Winkelman C; Zochodne DW; Ali NA; ;
    Am J Respir Crit Care Med; 2014 Dec; 190(12):1437-46. PubMed ID: 25496103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside use and intensive care unit-acquired weakness: A systematic review and meta-analysis.
    Yang T; Li ZQ; Li HL; Zhou JX; Chen GQ
    PLoS One; 2020; 15(3):e0230181. PubMed ID: 32191708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis of the association between vasopressor use and intensive care unit-acquired weakness.
    Yang T; Wang Y; Xi X; Yu S
    Brain Behav; 2024 Sep; 14(9):e70012. PubMed ID: 39236113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Care and treatments related to intensive care unit-acquired muscle weakness: A cohort study.
    Raurell-Torredà M; Arias-Rivera S; Martí JD; Frade-Mera MJ; Zaragoza-García I; Gallart E; Velasco-Sanz TR; San José-Arribas A; Blazquez-Martínez E;
    Aust Crit Care; 2021 Sep; 34(5):435-445. PubMed ID: 33663950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of high risk factors of intensive care unit-acquired weakness in patients with sepsis].
    Yu X; Wan X; Wan L; Huang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Apr; 30(4):355-359. PubMed ID: 29663999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive care unit-acquired weakness and the COVID-19 pandemic: A clinical review.
    Qin ES; Hough CL; Andrews J; Bunnell AE
    PM R; 2022 Feb; 14(2):227-238. PubMed ID: 35014183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteral nutrition management in critically ill adult patients and its relationship with intensive care unit-acquired muscle weakness: A national cohort study.
    Zaragoza-García I; Arias-Rivera S; Frade-Mera MJ; Martí JD; Gallart E; San José-Arribas A; Velasco-Sanz TR; Blazquez-Martínez E; Raurell-Torredà M
    PLoS One; 2023; 18(6):e0286598. PubMed ID: 37285356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Care Unit-Acquired Weakness in Patients With COVID-19: Occurrence and Associated Factors.
    Schmidt D; Piva TC; Glaeser SS; Piekala DM; Berto PP; Friedman G; Sbruzzi G
    Phys Ther; 2022 May; 102(5):. PubMed ID: 35233607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of neuromuscular electrical stimulation in critically ill patients.
    Segers J; Hermans G; Bruyninckx F; Meyfroidt G; Langer D; Gosselink R
    J Crit Care; 2014 Dec; 29(6):1082-8. PubMed ID: 25108833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.